GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grape King Bio Ltd (TPE:1707) » Definitions » Beneish M-Score

Grape King Bio (TPE:1707) Beneish M-Score : -2.48 (As of Apr. 07, 2025)


View and export this data going back to 1982. Start your Free Trial

What is Grape King Bio Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.48 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Grape King Bio's Beneish M-Score or its related term are showing as below:

TPE:1707' s Beneish M-Score Range Over the Past 10 Years
Min: -3.11   Med: -2.73   Max: -2.2
Current: -2.48

During the past 13 years, the highest Beneish M-Score of Grape King Bio was -2.20. The lowest was -3.11. And the median was -2.73.


Grape King Bio Beneish M-Score Historical Data

The historical data trend for Grape King Bio's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grape King Bio Beneish M-Score Chart

Grape King Bio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.11 -2.33 -3.07 -2.69 -2.48

Grape King Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.69 -2.78 -2.41 -2.79 -2.48

Competitive Comparison of Grape King Bio's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grape King Bio's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Grape King Bio's Beneish M-Score falls into.


;
;

Grape King Bio Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Grape King Bio for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0138+0.528 * 1.0346+0.404 * 1.0862+0.892 * 1.0493+0.115 * 0.9153
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9726+4.679 * -0.027905-0.327 * 0.9176
=-2.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was NT$336 Mil.
Revenue was 3154.981 + 2899.237 + 2758.268 + 2347.519 = NT$11,160 Mil.
Gross Profit was 2470.883 + 2265.315 + 2164.473 + 1756.884 = NT$8,658 Mil.
Total Current Assets was NT$5,596 Mil.
Total Assets was NT$15,324 Mil.
Property, Plant and Equipment(Net PPE) was NT$7,886 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$513 Mil.
Selling, General, & Admin. Expense(SGA) was NT$5,866 Mil.
Total Current Liabilities was NT$3,323 Mil.
Long-Term Debt & Capital Lease Obligation was NT$107 Mil.
Net Income was 446.772 + 415.887 + 327.759 + 257.881 = NT$1,448 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was 1210.121 + 460.967 + 91.603 + 113.221 = NT$1,876 Mil.
Total Receivables was NT$315 Mil.
Revenue was 3200.418 + 2550.692 + 2664.651 + 2219.703 = NT$10,635 Mil.
Gross Profit was 2553.183 + 2011.029 + 2190.97 + 1780.832 = NT$8,536 Mil.
Total Current Assets was NT$6,039 Mil.
Total Assets was NT$15,512 Mil.
Property, Plant and Equipment(Net PPE) was NT$7,756 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$460 Mil.
Selling, General, & Admin. Expense(SGA) was NT$5,747 Mil.
Total Current Liabilities was NT$3,647 Mil.
Long-Term Debt & Capital Lease Obligation was NT$136 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(335.53 / 11160.005) / (315.394 / 10635.464)
=0.030065 / 0.029655
=1.0138

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8536.014 / 10635.464) / (8657.555 / 11160.005)
=0.802599 / 0.775766
=1.0346

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5596.174 + 7885.529) / 15323.638) / (1 - (6038.777 + 7756.422) / 15511.841)
=0.120202 / 0.110667
=1.0862

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=11160.005 / 10635.464
=1.0493

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(459.763 / (459.763 + 7756.422)) / (513.484 / (513.484 + 7885.529))
=0.055958 / 0.061136
=0.9153

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5865.792 / 11160.005) / (5747.328 / 10635.464)
=0.525608 / 0.540393
=0.9726

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((106.963 + 3323.043) / 15323.638) / ((136.36 + 3647.384) / 15511.841)
=0.223838 / 0.243926
=0.9176

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1448.299 - 0 - 1875.912) / 15323.638
=-0.027905

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Grape King Bio has a M-score of -2.48 suggests that the company is unlikely to be a manipulator.


Grape King Bio Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Grape King Bio's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Grape King Bio Business Description

Traded in Other Exchanges
N/A
Address
No. 402, Jinling Road, Section 2, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in the production and sales of pharmaceutical preparation, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the Company's development and manufacturing products for Pro-partner Inc, Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others and it derives a majority of its revenue from Taiwan.

Grape King Bio Headlines

No Headlines